London, UK 9/9/14; Cambridge, UK 9/9/14—Abcam, a publicly held provider of protein-research tools and services, announced the appointment of Alan Hirzel as CEO, effective immediately. He replaces Jonathan Milner, PhD, who will now serve as deputy chairman. Mr. Hirzel previously served as chief marketing officer. “Alan will take over the leadership of the company, with Jonathan remaining involved in helping to identify and capitalize on important technological developments in the market and business development opportunities,” stated Murray Hennessy, chairman designate. “Abcam continues to grow and is now entering the next phase of its development. The Board felt that Alan, with his keen focus on the customer and significant global business experience, was the ideal candidate to lead the company through this.”